No Data
No Data
BEIGENE (688235.SH) released its performance for the year 2024, with revenue of 27.214 billion yuan, a year-on-year increase of 56.19%.
BEIGENE (688235.SH) released its annual report for 2024, with the revenue for the year 2024 being 27...
BeiGene Shenzhou Co., Ltd. 2024 Annual Report
BeiGene Shenzhou Co., Ltd. 2024 Annual Report Summary
Express News | RBC Capital Reiterates Outperform on BeiGene, Maintains $312 Price Target
BeiGene Analyst Ratings
US Stock Movement | BEIGENE (ONC.US) rises over 2% Institutions: Innovative Drugs from mainland China are not affected by tariffs when going overseas.
On Monday, BEIGENE (ONC.US) rose over 2%, closing at $251.10.